Bexsero, meningitis B vaccine, to be available for babies in the UK

Finally, a deal has been reached on the price of the meningococcal B vaccine, Bexsero, and the life-saving vaccine will become part of national childhood immunization schedule in the United Kingdom. The back-and-forth between the UK government and GlaxoSmithKline, which acquired the vaccine 3 weeks ago, ended with an agreement. In a statement from London, the pharmaceutical ["]